A Phase 1b Study of TRC105 In Combination with Paclitaxel/Carboplatin and Bevacizumab in Patients with Stage 4 Non-Squamous Cell Lung Cancer

Authors
Category Primary study
JournalJournal of Thoracic Oncology
Year 2018
This article has no abstract
Epistemonikos ID: 4529f26a3bd3b7b14a0ed6996d96148daabdd6c8
First added on: Feb 09, 2025